3D Bioprinting
Readiness
TRL 4 · SRL 3.5 · gap +0.5
Gap = technical readiness − societal readiness. Positive: the technology is ready and society is not. Negative: society wants it more than the technology can deliver.
Not scored. Watchlist entries do not enter any gradient.
Printing living tissue by depositing bio-inks — living cells suspended in biopolymers — layer by layer into a structure that can be kept alive.
What works today is real and narrower than the headline. Printed skin, cartilage and simple tissue constructs are in clinical use or trials, and printed tissue for drug testing is an established laboratory product. What does not work is the solid organ, and the reason is vasculature: any tissue thicker than a millimetre or two needs a blood supply threaded through it at capillary scale, and printing that network at the resolution cells require, in a structure that survives being connected to a circulation, is the unsolved problem.
Readiness is low on both axes, 4 and 3.5, and the closeness is itself honest. Nobody in this field is overselling to the public; the overselling happens in funding rounds.
Common misconception: that printed organs solve the transplant shortage on a foreseeable timescale. The tissue engineering is decades of work, and the near-term contribution is to drug testing, where it may reduce animal use considerably sooner.
What it does
mechanism — not yet written. Published as missing rather than hidden.